PNC Financial Services Group
ODT

PNC Financial Services Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

PNC Financial Services Group’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-66
Closed – – 4483
2021
Q2 		$0 Hold
66
– – ﹤0.01% 4347
2021
Q1 		$0 Hold
66
– – ﹤0.01% 4260
2020
Q4 		$2K Hold
66
– – ﹤0.01% 3873
2020
Q3 		$0 Hold
66
– – ﹤0.01% 4122
2020
Q2 		$2K Hold
66
– – ﹤0.01% 3817
2020
Q1 		$2K Hold
66
– – ﹤0.01% 3773
2019
Q4 		$2K Sell
66
-6
-8% -$186 ﹤0.01% 3830
2019
Q3 		$2K Hold
72
– – ﹤0.01% 3888
2019
Q2 		$2K Hold
72
– – ﹤0.01% 3902
2019
Q1 		$2K Hold
72
– – ﹤0.01% 3906
2018
Q4 		$2K Hold
72
– – ﹤0.01% 3894
2018
Q3 		$2K Hold
72
– – ﹤0.01% 3987
2018
Q2 		$2K Hold
72
– – ﹤0.01% 4011
2018
Q1 		$2K Buy
+72
New +$1.7K ﹤0.01% 4073

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's ODT Position: Q3 2021 in Review

PNC Financial Services Group sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q3 2021, closing a stake of 66 shares.

PNC Financial Services Group first reported a position in ODT in Q1 2018 and held it in 14 quarters. The position peaked at $2K in Q4 2020. 58 funds tracked by Wall St. Rank hold ODT as of Q3 2021.

  • PNC Financial Services Group reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 66 Odonate Therapeutics, Inc. Common Stock shares in Q3 2021.
  • PNC Financial Services Group first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 14 quarters.
  • PNC Financial Services Group's Odonate Therapeutics, Inc. Common Stock position peaked at $2K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q3 2021.

Based on PNC Financial Services Group's 13F filing for Q3 2021, filed 5 Nov 2021.